|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development (note 20) | |||||
| General and administrative (note 20) | |||||
| Loss before the following | |||||
| Change in fair value of warrant derivative (notes 9, 17) | |||||
| Foreign exchange gain (loss) | |||||
| Interest income, net | |||||
| Income tax expense (note 15) | |||||
| Translation adjustment | |||||
| Basic loss per common share (cad per share) | |||||
| Weighted average number of shares (basic) (shares) | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Change in fair value of warrant derivative | |||||
| Fair value loss from Standby Equity Purchase Agreement (“SEPA Arrangement”) | |||||
| Foreign exchange (loss) gain | |||||
| Interest income | |||||
| Total other income, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Other comprehensive loss: | |||||
| Translation adjustments | |||||
| Comprehensive loss | |||||
| Basic net loss per common share (in dollars per share) | |||||
| Diluted net loss per common share (in dollars per share) | |||||
| Weighted average number of common shares used in computing net loss per share, basic (in shares) | |||||
| Weighted average number of common shares used in computing net loss per share, diluted (in shares) |
Loading...